Diabetes poses a major healthcare challenge given its rising prevalence, cost, and risk of chronic complications and co-morbidities. Healthcare providers are required to address these concerns in a changing landscape of therapy and technology where treatments for diabetes continue to expand. The annual UCLA Diabetes Symposium is a full-day CME program offering providers of varying backgrounds a chance to review optimal state-of-the-art patient care. Experts in the field will review current best practices, including updates in care, guidelines, and new medication classes, as well as address co-morbidities including cardiovascular disease and obesity.
Please click the register button on top to enroll. You may use your credit cards or choose the ACH option to process payment.*
*Credit card and check payments via phone, fax, or mail are no longer accepted.
$150 Nurses (RNs), Allied Health Professionals and Students
Cancellations must be received by email to firstname.lastname@example.org by October 27, 2023, and will be subject to a $75 processing fee. No refunds will be granted after that date. If, for any reason, the course must be canceled, discontinued, or rescheduled, a full refund will be provided.
If you have questions about enrollment, please email email@example.com or call (310) 794-2620.
Please visit the Ritz Carlton-Marina del Rey website (Link) to make a reservation. Please note that there is no room block for the course.
Valet day parking: $18
Please email ccpdSEG@mednet.ucla.edu.
At the completion of this course, participants should be able to:
- Counsel patients with diabetes on cardiovascular disease prevention
- Understand the role of insulin, SGLT-2 Inhibitors
- Understand the risks and benefits of Incretin (GLP-1, GIP) medications used in type 2 diabetes mellitus
- Counsel patients on the benefits of continuous glucose monitoring
- Understand risks related to obesity as well as the treatment via medications and surgery
- Recognize the heterogeneity of diabetes and how an accurate diagnosis informs treatment
The David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The David Geffen School of Medicine at UCLA, designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The FDA has issued a concept paper that classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is “truly independent” and free of commercial influence. In addition to independence, the FDA requires that non-promotional, commercially supported education be objective, balanced and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program’s participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manage all identified potential conflicts of interest prior to the program. UCLA fully endorses the letter and spirit of these concepts.